What remains against carbapenem-resistant Enterobacteriaceae? Evaluation of chloramphenicol, ciprofloxacin, colistin, fosfomycin, minocycline, nitrofurantoin, temocillin and tigecycline
- 1 May 2011
- journal article
- Published by Elsevier BV in International Journal of Antimicrobial Agents
- Vol. 37 (5), 415-419
- https://doi.org/10.1016/j.ijantimicag.2011.01.012
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Activity of aminoglycosides, including ACHN-490, against carbapenem-resistant Enterobacteriaceae isolatesJournal of Antimicrobial Chemotherapy, 2010
- Comparison of tigecycline with imipenem/cilastatin for the treatment of hospital-acquired pneumoniaDiagnostic Microbiology and Infectious Disease, 2010
- Hospital outbreak caused by Klebsiella pneumoniae producing KPC-2 β-lactamase resistant to colistinJournal of Hospital Infection, 2010
- Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological studyThe Lancet Infectious Diseases, 2010
- Emergence of a colistin-resistant KPC-2-producing Klebsiella pneumoniae ST258 clone in HungaryEuropean Journal of Clinical Microbiology & Infectious Diseases, 2010
- Spread of OXA-48-Encoding Plasmid in Turkey and BeyondAntimicrobial Agents and Chemotherapy, 2010
- Activity of Temocillin against KPC-Producing Klebsiella pneumoniae and Escherichia coliAntimicrobial Agents and Chemotherapy, 2009
- Tigecycline in the treatment of infections from multi-drug resistant gram-negative pathogensJournal of Infection, 2009
- Temocillin revivedJournal of Antimicrobial Chemotherapy, 2008
- Intravenous Colistin as Therapy for Nosocomial Infections Caused by Multidrug‐Resistant Pseudomonas aeruginosa and Acinetobacter baumanniiClinical Infectious Diseases, 1999